<?xml version="1.0" encoding="UTF-8"?>

<Library xmlns="http://hl7.org/fhir">
  <id value="HIVIND45Logic"/>
  <meta>
    <profile value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablelibrary"/>
    <profile value="http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablelibrary"/>
    <profile value="http://hl7.org/fhir/uv/cql/StructureDefinition/cql-library"/>
    <profile value="http://hl7.org/fhir/uv/cql/StructureDefinition/cql-module"/>
  </meta>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Library HIVIND45Logic</b></p><a name="HIVIND45Logic"> </a><a name="hcHIVIND45Logic"> </a><a name="hcHIVIND45Logic-en-US"> </a><h2>Contents</h2><p><code>text/cql</code></p><pre><code class="language-sql">/*
 * Library: HIV.IND.45 Logic
 * Ref No: TBH.2
 * Short Name: TPT completion
 *
 * Definition: Number and % of people living with HIV on ART who completed a course of TB preventive treatment among those who initiated TPT
 *
 * Numerator: Number of ART patients who completed a course of TPT during the reporting period
 * Numerator Calculation: COUNT of clients with &quot;HIV status&quot;='HIV-positive' AND &quot;On ART&quot;=True AND &quot;TB preventive treatment (TPT) start date&quot; in the previous period AND &quot;TB preventive treatment (TPT) status&quot;='Completed'
 * Numerator Exclusions: 
 *
 * Denominator: Number of ART patients who initiated any course of TPT during the previous reporting period
 * Denominator Calculation: COUNT of clients with &quot;HIV status&quot;='HIV-positive' AND &quot;On ART&quot;=True AND &quot;TB preventive treatment (TPT) start date&quot; in the prior reporting period
 * Denominator Exclusions: 
 *
 * Disaggregations:
 * • Gender (female, male, other*)
 * • Age (0–4, 5–9, 10–14, 15–19, 20–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50+ years)**
 * • Type of TPT regimen
 * • ART initiation (&lt;12 months on ART, 12+ months on ART)
 * • Cities and other administrative regions of epidemiologic importance
 * 
 * Disaggregation Elements: Gender | Age | TPT regimen type | ART start date (&lt;12 months on ART, ≥12 months on ART)
 *
 * Numerator and Denominator Elements:
 * HIV status | On ART | TB preventive treatment (TPT) start date | TB preventive treatment (TPT) status
 *
 * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022
 * 
 * Data Concepts:
 *  
 * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth 
 * HIV.A.DE18: Gender* | Gender of the client* 
 * HIV.A.DE19: Female | Client identifies as female 
 * HIV.A.DE20: Male | Client identifies as male 
 * HIV.A.DE21: Transgender male | Client identifies as transgender male 
 * HIV.A.DE22: Transgender female | Client identifies as transgender female 
 * HIV.A.DE23: Other | Additional category 
 * HIV.B.DE72: ART start date | The date on which the client started or restarted antiretroviral therapy (ART) 
 * HIV.B.DE115: HIV status | HIV status reported after applying the national HIV testing algorithm. No single HIV test can provide an HIV-positive diagnosis. 
 * HIV.B.DE116: HIV-positive | Client is HIV-positive 
 * HIV.B.DE117: HIV-negative | Client is HIV-negative 
 * HIV.B.DE118: Unknown | Client has unknown HIV status 
 * HIV.D.DE38: On ART | Client is currently taking ART 
 * HIV.D.DE39: ART start date | The date on which the client started or restarted ART 
 * HIV.D.DE954: TB preventive treatment (TPT) start date | The date on which the client began taking TPT 
 * HIV.D.DE1028: TPT regimen type | Type of TPT regimen the client is currently on 
 * HIV.D.DE1029: 3HP | The client's current TPT regimen is 3HP 
 * HIV.D.DE1030: 1HP | The client's current TPT regimen is 1HP 
 * HIV.D.DE1031: 6H | The client's current TPT regimen is 6H 
 * HIV.D.DE1032: Six months of levofloxacin daily | The client's current TPT regimen is six months of levofloxacin daily 
 * HIV.D.DE1033: Other TB preventive treatment (TPT) regimen | The client's current TPT regimen is another regimen than those listed above 
 * HIV.D.DE1034: TB preventive treatment (TPT) status | Indicates the current status of TB preventive treatment (TPT) 
 * HIV.D.DE1035: Not started | The client did not start the TB preventive treatment (TPT) 
 * HIV.D.DE1036: On TPT | The client started the TB preventive treatment (TPT) and is currently taking the medication, without treatment interruptions 
 * HIV.D.DE1037: On TPT with interruptions | The client started the TB preventive treatment (TPT) and is currently taking the medication, with treatment interruptions 
 * HIV.D.DE1038: On hold | The health care worker has temporarily stopped the TB preventive treatment (TPT), but TPT is expected to continue again later. May also be called &quot;suspended&quot;. 
 * HIV.D.DE1039: Completed | TB preventive treatment (TPT) was completed 
 * HIV.H.DE47: On ART | Client is currently taking ART 
 *
 * Additional Context
 * - what it measures: This indicator measures the effectiveness of scaled-up TPT programmes by assessing the proportion of patients who completed the recommended course of TPT.
 * - rationale: • Many countries have made progress in initiating eligible people living with HIV on TPT. However, rates of TPT completion remain poor or unknown. | • Assessment of TPT completion is a critical element of the TB/HIV cascade of services.
 * - method: For the numerator and denominator: Programme records (for example, ART registers) |  | Defining &quot;previous reporting period&quot;: For example, for annual reporting of January to December 2021, the previous reporting period is January to December 2020 (except for programmes with 1HP-exclusive national guidelines and implementation, in which case they may use January to December 2021). For quarterly or semi-annual reporting to the national level, the previous reporting period will depend on the TPT regimen and duration defined by national guidelines. |  | Note: For programmes using continuous isoniazid preventive therapy (IPT), TPT completion is defined as six months of treatment. | 
 * 
 * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm
 */

library HIVIND45Logic

// Included Libraries
using FHIR version '4.0.1'

include HIVIndicatorCommon version '0.0.1' called HIC
include FHIRHelpers version '4.0.1'
include WHOCommon called WCom
include FHIRCommon called FC

// Indicator Definition
</code></pre><p><code>No Content</code> (<code>application/elm+xml</code>)</p></div>
  </text>
  <extension url="http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability">
    <valueCode value="computable"/>
  </extension>
  <url value="http://smart.who.int/HIV/Library/HIVIND45Logic"/>
  <version value="0.1.0"/>
  <name value="HIVIND45Logic"/>
  <title value="HIV.IND.45 Logic"/>
  <status value="draft"/>
  <experimental value="true"/>
  <type>
    <coding>
      <system value="http://terminology.hl7.org/CodeSystem/library-type"/>
      <code value="logic-library"/>
    </coding>
  </type>
  <date value="2024-07-01T05:12:03+00:00"/>
  <publisher value="WHO"/>
  <contact>
    <name value="WHO"/>
    <telecom>
      <system value="url"/>
      <value value="http://who.int"/>
    </telecom>
  </contact>
  <description value="Number and % of people living with HIV on ART who completed a course of TB preventive treatment among those who initiated TPT"/>
  <content>
    <contentType value="text/cql"/>
    <data value="LyoKICogTGlicmFyeTogSElWLklORC40NSBMb2dpYwogKiBSZWYgTm86IFRCSC4yCiAqIFNob3J0IE5hbWU6IFRQVCBjb21wbGV0aW9uCiAqCiAqIERlZmluaXRpb246IE51bWJlciBhbmQgJSBvZiBwZW9wbGUgbGl2aW5nIHdpdGggSElWIG9uIEFSVCB3aG8gY29tcGxldGVkIGEgY291cnNlIG9mIFRCIHByZXZlbnRpdmUgdHJlYXRtZW50IGFtb25nIHRob3NlIHdobyBpbml0aWF0ZWQgVFBUCiAqCiAqIE51bWVyYXRvcjogTnVtYmVyIG9mIEFSVCBwYXRpZW50cyB3aG8gY29tcGxldGVkIGEgY291cnNlIG9mIFRQVCBkdXJpbmcgdGhlIHJlcG9ydGluZyBwZXJpb2QKICogTnVtZXJhdG9yIENhbGN1bGF0aW9uOiBDT1VOVCBvZiBjbGllbnRzIHdpdGggIkhJViBzdGF0dXMiPSdISVYtcG9zaXRpdmUnIEFORCAiT24gQVJUIj1UcnVlIEFORCAiVEIgcHJldmVudGl2ZSB0cmVhdG1lbnQgKFRQVCkgc3RhcnQgZGF0ZSIgaW4gdGhlIHByZXZpb3VzIHBlcmlvZCBBTkQgIlRCIHByZXZlbnRpdmUgdHJlYXRtZW50IChUUFQpIHN0YXR1cyI9J0NvbXBsZXRlZCcKICogTnVtZXJhdG9yIEV4Y2x1c2lvbnM6IAogKgogKiBEZW5vbWluYXRvcjogTnVtYmVyIG9mIEFSVCBwYXRpZW50cyB3aG8gaW5pdGlhdGVkIGFueSBjb3Vyc2Ugb2YgVFBUIGR1cmluZyB0aGUgcHJldmlvdXMgcmVwb3J0aW5nIHBlcmlvZAogKiBEZW5vbWluYXRvciBDYWxjdWxhdGlvbjogQ09VTlQgb2YgY2xpZW50cyB3aXRoICJISVYgc3RhdHVzIj0nSElWLXBvc2l0aXZlJyBBTkQgIk9uIEFSVCI9VHJ1ZSBBTkQgIlRCIHByZXZlbnRpdmUgdHJlYXRtZW50IChUUFQpIHN0YXJ0IGRhdGUiIGluIHRoZSBwcmlvciByZXBvcnRpbmcgcGVyaW9kCiAqIERlbm9taW5hdG9yIEV4Y2x1c2lvbnM6IAogKgogKiBEaXNhZ2dyZWdhdGlvbnM6CiAqIOKAosKgR2VuZGVyIChmZW1hbGUsIG1hbGUsIG90aGVyKikKICog4oCiIEFnZSAoMOKAkzQsIDXigJM5LCAxMOKAkzE0LCAxNeKAkzE5LCAyMOKAkzI0LCAyNeKAkzI5LCAzMOKAkzM0LCAzNeKAkzM5LCA0MOKAkzQ0LCA0NeKAkzQ5LCA1MCsgeWVhcnMpKioKICog4oCiwqBUeXBlIG9mIFRQVCByZWdpbWVuCiAqIOKAoiBBUlQgaW5pdGlhdGlvbiAoPDEyIG1vbnRocyBvbiBBUlQsIDEyKyBtb250aHMgb24gQVJUKQogKiDigKIgQ2l0aWVzIGFuZCBvdGhlciBhZG1pbmlzdHJhdGl2ZSByZWdpb25zIG9mIGVwaWRlbWlvbG9naWMgaW1wb3J0YW5jZQogKiAKICogRGlzYWdncmVnYXRpb24gRWxlbWVudHM6IEdlbmRlciB8IEFnZSB8IFRQVCByZWdpbWVuIHR5cGUgfCBBUlQgc3RhcnQgZGF0ZSAoPDEyIG1vbnRocyBvbiBBUlQsIOKJpTEyIG1vbnRocyBvbiBBUlQpCiAqCiAqIE51bWVyYXRvciBhbmQgRGVub21pbmF0b3IgRWxlbWVudHM6CiAqIEhJViBzdGF0dXMgfCBPbiBBUlQgfCBUQiBwcmV2ZW50aXZlIHRyZWF0bWVudCAoVFBUKSBzdGFydCBkYXRlIHwgVEIgcHJldmVudGl2ZSB0cmVhdG1lbnQgKFRQVCkgc3RhdHVzCiAqCiAqIFJlZmVyZW5jZTogQ29uc29saWRhdGVkIGd1aWRlbGluZXMgb24gcGVyc29uLWNlbnRyZWQgSElWIHN0cmF0ZWdpYyBpbmZvcm1hdGlvbjogc3RyZW5ndGhlbmluZyByb3V0aW5lIGRhdGEgZm9yIGltcGFjdC4gR2VuZXZhOiBXb3JsZCBIZWFsdGggT3JnYW5pemF0aW9uOyAyMDIyCiAqIAogKiBEYXRhIENvbmNlcHRzOgogKiAgCiAqIEhJVi5BLkRFMTc6IEFnZSB8IENhbGN1bGF0ZWQgYWdlIChudW1iZXIgb2YgeWVhcnMpIG9mIHRoZSBjbGllbnQgYmFzZWQgb24gZGF0ZSBvZiBiaXJ0aCAKICogSElWLkEuREUxODogR2VuZGVyKiB8IEdlbmRlciBvZiB0aGUgY2xpZW50KiAKICogSElWLkEuREUxOTogRmVtYWxlIHwgQ2xpZW50IGlkZW50aWZpZXMgYXMgZmVtYWxlIAogKiBISVYuQS5ERTIwOiBNYWxlIHwgQ2xpZW50IGlkZW50aWZpZXMgYXMgbWFsZSAKICogSElWLkEuREUyMTogVHJhbnNnZW5kZXIgbWFsZSB8IENsaWVudCBpZGVudGlmaWVzIGFzIHRyYW5zZ2VuZGVyIG1hbGUgCiAqIEhJVi5BLkRFMjI6IFRyYW5zZ2VuZGVyIGZlbWFsZSB8IENsaWVudCBpZGVudGlmaWVzIGFzIHRyYW5zZ2VuZGVyIGZlbWFsZSAKICogSElWLkEuREUyMzogT3RoZXIgfCBBZGRpdGlvbmFsIGNhdGVnb3J5IAogKiBISVYuQi5ERTcyOiBBUlQgc3RhcnQgZGF0ZSB8IFRoZSBkYXRlIG9uIHdoaWNoIHRoZSBjbGllbnQgc3RhcnRlZCBvciByZXN0YXJ0ZWQgYW50aXJldHJvdmlyYWwgdGhlcmFweSAoQVJUKSAKICogSElWLkIuREUxMTU6IEhJViBzdGF0dXMgfCBISVYgc3RhdHVzIHJlcG9ydGVkIGFmdGVyIGFwcGx5aW5nIHRoZSBuYXRpb25hbCBISVYgdGVzdGluZyBhbGdvcml0aG0uIE5vIHNpbmdsZSBISVYgdGVzdCBjYW4gcHJvdmlkZSBhbiBISVYtcG9zaXRpdmUgZGlhZ25vc2lzLiAKICogSElWLkIuREUxMTY6IEhJVi1wb3NpdGl2ZSB8IENsaWVudCBpcyBISVYtcG9zaXRpdmUgCiAqIEhJVi5CLkRFMTE3OiBISVYtbmVnYXRpdmUgfCBDbGllbnQgaXMgSElWLW5lZ2F0aXZlIAogKiBISVYuQi5ERTExODogVW5rbm93biB8IENsaWVudCBoYXMgdW5rbm93biBISVYgc3RhdHVzIAogKiBISVYuRC5ERTM4OiBPbiBBUlQgfCBDbGllbnQgaXMgY3VycmVudGx5IHRha2luZyBBUlQgCiAqIEhJVi5ELkRFMzk6IEFSVCBzdGFydCBkYXRlIHwgVGhlIGRhdGUgb24gd2hpY2ggdGhlIGNsaWVudCBzdGFydGVkIG9yIHJlc3RhcnRlZCBBUlQgCiAqIEhJVi5ELkRFOTU0OiBUQiBwcmV2ZW50aXZlIHRyZWF0bWVudCAoVFBUKSBzdGFydCBkYXRlIHwgVGhlIGRhdGUgb24gd2hpY2ggdGhlIGNsaWVudCBiZWdhbiB0YWtpbmcgVFBUIAogKiBISVYuRC5ERTEwMjg6IFRQVCByZWdpbWVuIHR5cGUgfCBUeXBlIG9mIFRQVCByZWdpbWVuIHRoZSBjbGllbnQgaXMgY3VycmVudGx5IG9uIAogKiBISVYuRC5ERTEwMjk6IDNIUCB8IFRoZSBjbGllbnQncyBjdXJyZW50IFRQVCByZWdpbWVuIGlzIDNIUCAKICogSElWLkQuREUxMDMwOiAxSFAgfCBUaGUgY2xpZW50J3MgY3VycmVudCBUUFQgcmVnaW1lbiBpcyAxSFAgCiAqIEhJVi5ELkRFMTAzMTogNkggfCBUaGUgY2xpZW50J3MgY3VycmVudCBUUFQgcmVnaW1lbiBpcyA2SCAKICogSElWLkQuREUxMDMyOiBTaXggbW9udGhzIG9mIGxldm9mbG94YWNpbiBkYWlseSB8IFRoZSBjbGllbnQncyBjdXJyZW50IFRQVCByZWdpbWVuIGlzIHNpeCBtb250aHMgb2YgbGV2b2Zsb3hhY2luIGRhaWx5IAogKiBISVYuRC5ERTEwMzM6IE90aGVyIFRCIHByZXZlbnRpdmUgdHJlYXRtZW50IChUUFQpIHJlZ2ltZW4gfCBUaGUgY2xpZW50J3MgY3VycmVudCBUUFQgcmVnaW1lbiBpcyBhbm90aGVyIHJlZ2ltZW4gdGhhbiB0aG9zZSBsaXN0ZWQgYWJvdmUgCiAqIEhJVi5ELkRFMTAzNDogVEIgcHJldmVudGl2ZSB0cmVhdG1lbnQgKFRQVCkgc3RhdHVzIHwgSW5kaWNhdGVzIHRoZSBjdXJyZW50IHN0YXR1cyBvZiBUQiBwcmV2ZW50aXZlIHRyZWF0bWVudCAoVFBUKSAKICogSElWLkQuREUxMDM1OiBOb3Qgc3RhcnRlZCB8IFRoZSBjbGllbnQgZGlkIG5vdCBzdGFydCB0aGUgVEIgcHJldmVudGl2ZSB0cmVhdG1lbnQgKFRQVCkgCiAqIEhJVi5ELkRFMTAzNjogT24gVFBUIHwgVGhlIGNsaWVudCBzdGFydGVkIHRoZSBUQiBwcmV2ZW50aXZlIHRyZWF0bWVudCAoVFBUKSBhbmQgaXMgY3VycmVudGx5IHRha2luZyB0aGUgbWVkaWNhdGlvbiwgd2l0aG91dCB0cmVhdG1lbnQgaW50ZXJydXB0aW9ucyAKICogSElWLkQuREUxMDM3OiBPbiBUUFQgd2l0aCBpbnRlcnJ1cHRpb25zIHwgVGhlIGNsaWVudCBzdGFydGVkIHRoZSBUQiBwcmV2ZW50aXZlIHRyZWF0bWVudCAoVFBUKSBhbmQgaXMgY3VycmVudGx5IHRha2luZyB0aGUgbWVkaWNhdGlvbiwgd2l0aCB0cmVhdG1lbnQgaW50ZXJydXB0aW9ucyAKICogSElWLkQuREUxMDM4OiBPbiBob2xkIHwgVGhlIGhlYWx0aCBjYXJlIHdvcmtlciBoYXMgdGVtcG9yYXJpbHkgc3RvcHBlZCB0aGUgVEIgcHJldmVudGl2ZSB0cmVhdG1lbnQgKFRQVCksIGJ1dCBUUFQgaXMgZXhwZWN0ZWQgdG8gY29udGludWUgYWdhaW4gbGF0ZXIuIE1heSBhbHNvIGJlIGNhbGxlZCAic3VzcGVuZGVkIi4gCiAqIEhJVi5ELkRFMTAzOTogQ29tcGxldGVkIHwgVEIgcHJldmVudGl2ZSB0cmVhdG1lbnQgKFRQVCkgd2FzIGNvbXBsZXRlZCAKICogSElWLkguREU0NzogT24gQVJUIHwgQ2xpZW50IGlzIGN1cnJlbnRseSB0YWtpbmcgQVJUIAogKgogKiBBZGRpdGlvbmFsIENvbnRleHQKICogLSB3aGF0IGl0IG1lYXN1cmVzOiBUaGlzIGluZGljYXRvciBtZWFzdXJlcyB0aGUgZWZmZWN0aXZlbmVzcyBvZiBzY2FsZWQtdXAgVFBUIHByb2dyYW1tZXMgYnkgYXNzZXNzaW5nIHRoZSBwcm9wb3J0aW9uIG9mIHBhdGllbnRzIHdobyBjb21wbGV0ZWQgdGhlIHJlY29tbWVuZGVkIGNvdXJzZSBvZiBUUFQuCiAqIC0gcmF0aW9uYWxlOiDigKLCoE1hbnkgY291bnRyaWVzIGhhdmUgbWFkZSBwcm9ncmVzcyBpbiBpbml0aWF0aW5nIGVsaWdpYmxlIHBlb3BsZSBsaXZpbmcgd2l0aCBISVYgb24gVFBULiBIb3dldmVyLCByYXRlcyBvZiBUUFQgY29tcGxldGlvbiByZW1haW4gcG9vciBvciB1bmtub3duLiB8IOKAosKgQXNzZXNzbWVudCBvZiBUUFQgY29tcGxldGlvbiBpcyBhIGNyaXRpY2FsIGVsZW1lbnQgb2YgdGhlIFRCL0hJViBjYXNjYWRlIG9mIHNlcnZpY2VzLgogKiAtIG1ldGhvZDogRm9yIHRoZSBudW1lcmF0b3IgYW5kIGRlbm9taW5hdG9yOiBQcm9ncmFtbWUgcmVjb3JkcyAoZm9yIGV4YW1wbGUsIEFSVCByZWdpc3RlcnMpIHwgIHwgRGVmaW5pbmcgInByZXZpb3VzIHJlcG9ydGluZyBwZXJpb2QiOiBGb3IgZXhhbXBsZSwgZm9yIGFubnVhbCByZXBvcnRpbmcgb2YgSmFudWFyeSB0byBEZWNlbWJlciAyMDIxLCB0aGUgcHJldmlvdXMgcmVwb3J0aW5nIHBlcmlvZCBpcyBKYW51YXJ5IHRvIERlY2VtYmVyIDIwMjAgKGV4Y2VwdCBmb3IgcHJvZ3JhbW1lcyB3aXRoIDFIUC1leGNsdXNpdmUgbmF0aW9uYWwgZ3VpZGVsaW5lcyBhbmQgaW1wbGVtZW50YXRpb24sIGluIHdoaWNoIGNhc2UgdGhleSBtYXkgdXNlIEphbnVhcnkgdG8gRGVjZW1iZXIgMjAyMSkuIEZvciBxdWFydGVybHkgb3Igc2VtaS1hbm51YWwgcmVwb3J0aW5nIHRvIHRoZSBuYXRpb25hbCBsZXZlbCwgdGhlIHByZXZpb3VzIHJlcG9ydGluZyBwZXJpb2Qgd2lsbCBkZXBlbmQgb24gdGhlIFRQVCByZWdpbWVuIGFuZCBkdXJhdGlvbiBkZWZpbmVkIGJ5IG5hdGlvbmFsIGd1aWRlbGluZXMuIHwgIHwgTm90ZTogRm9yIHByb2dyYW1tZXMgdXNpbmcgY29udGludW91cyBpc29uaWF6aWQgcHJldmVudGl2ZSB0aGVyYXB5IChJUFQpLCBUUFQgY29tcGxldGlvbiBpcyBkZWZpbmVkIGFzIHNpeCBtb250aHMgb2YgdHJlYXRtZW50LiB8IAogKiAKICogU3VnZ2VzdGVkIFNjb3JpbmcgTWV0aG9kOiBwcm9wb3J0aW9uIHwgaHR0cDovL2hsNy5vcmcvZmhpci91cy9jcWZtZWFzdXJlcy9TdHJ1Y3R1cmVEZWZpbml0aW9uL3Byb3BvcnRpb24tbWVhc3VyZS1jcWZtCiAqLwoKbGlicmFyeSBISVZJTkQ0NUxvZ2ljCgovLyBJbmNsdWRlZCBMaWJyYXJpZXMKdXNpbmcgRkhJUiB2ZXJzaW9uICc0LjAuMScKCmluY2x1ZGUgSElWSW5kaWNhdG9yQ29tbW9uIHZlcnNpb24gJzAuMC4xJyBjYWxsZWQgSElDCmluY2x1ZGUgRkhJUkhlbHBlcnMgdmVyc2lvbiAnNC4wLjEnCmluY2x1ZGUgV0hPQ29tbW9uIGNhbGxlZCBXQ29tCmluY2x1ZGUgRkhJUkNvbW1vbiBjYWxsZWQgRkMKCi8vIEluZGljYXRvciBEZWZpbml0aW9uCg=="/>
  </content>
  <content>
    <contentType value="application/elm+xml"/>
  </content>
</Library>